NDA Group has appointed Andrew Monaghan, PhD as General Manager for NDA’s UK affiliate based in London. Prior to joining NDA Andrew worked at Worldwide Clinical trials as Global Head of Pharmacovigilance. His previous pharmaceutical positions includ: Head of Pharmacovigilance at Chiltern and 14 years at Roche/Genentech, where he started as EU Head of Regulatory Affairs and Global Head of Medical Writing, before taking on the role of Global Head of Clinical Management and then the Global Head of Drug Safety Operations. He also worked for Pfizer Central Research for 14 years.